Interleukin-12 in the treatment of chronic hepatitis B and C
- 16 October 2001
- journal article
- clinical trial
- Published by Elsevier in Antiviral Research
- Vol. 52 (2) , 181-188
- https://doi.org/10.1016/s0166-3542(01)00183-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Phase I/Ii Study of Recombinant Human Interleukin–12 in Patients With Chronic Hepatitis CHepatology, 1999
- Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus ChronicityHepatology, 1997
- Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.Journal of Clinical Investigation, 1996
- Interleukin-12: Potential Clinical Applications in the Treatment and Prevention of Infectious DiseasesDrugs, 1996
- Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.The Journal of Experimental Medicine, 1995
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivoEuropean Journal of Immunology, 1995
- In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).The Journal of Experimental Medicine, 1994
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- IL-12: Initiation Cytokine for Cell-Mediated ImmunityScience, 1993